Citywire A-rated Andrej Hrovat believes that the pharmaceutical sector is most likely to see another correction in the short term as big pharma firms continue to snap up biotech firms.
Citywire A-rated Andrej Hrovat believes that the pharmaceutical sector is most likely to see another correction in the short term as big pharma firms continue to snap up biotech firms.
